8-KFiling Date: Jul 6, 2026

AbbVie 8-K: Earnings Release, Financial Statements (Jul 6, 2026)

abbv-20260706

View SEC Filing

ACC: 0001551152-26-000021

Event Type

Earnings ReleaseFinancial Statements

Filing overview

AbbVie filed a Form 8-K (Material Event (8-K)) with the SEC on 2026-07-06. Reported items: Item 2.02 Earnings Release; Item 9.01 Financial Statements.

More filings from AbbVie

Recent 8-K filings from other companies

Richtech Robotics (RR) 8-K · Oct 2, 2026Executive Change; Shareholder Vote
Pinterest (PINS) 8-K · Oct 2, 2026Level 21 CIC severance expanded
Live Nation Entertainment (LYV) 8-K · Oct 2, 2026Executive Change; Financial Statements
Teledyne Technologies (TDY) 8-K/A · Oct 2, 2026Executive Change; Financial Statements
Nano Nuclear Energy (NNE) 8-K · Oct 2, 2026Material Agreement; Securities Issuance; Reg FD Disclosure; Financial…